West Nile virus blood transfusion-related infection despite nucleic acid testing

Transfusion

Volumn 44, Issue 12, 2004, Pages 1695-1699

  De Oliveira, Alexandre Macedo ^b   Beecham, Brady D ^b   Montgomery, Susan P ^b   Lanciotti, Robert S ^b   Linnen, Jeffrey M ^b   Giachetti, Cristina ^b   Pietrelli, Larry A ^b   Stramer, Susan L ^b   Safranek, Thomas J ^a  

^a Nebraska Department of Health and Human Services   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

AGED; ARTICLE; BLEEDING; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; FOLLOW UP; HUMAN; IMMUNOASSAY; INFECTION RISK; MALE; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; SEROCONVERSION; VIRUS ENCEPHALITIS; WEST NILE FLAVIVIRUS;

AGED; ANTIBODIES, VIRAL; BLOOD DONORS; BLOOD TRANSFUSION; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; MALE; RNA, VIRAL; WEST NILE FEVER; WEST NILE VIRUS;

EID: 10444220177     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2004.04130.x     Document Type: Article

References (22)

1. Nash D, Mostashari F, Fine A, et al. The outbreak ofWest Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807-14.
2. West Nile virus activity - United States, August 21-28, 2002, and Illinois, January 1-August 27, 2002. MMWR Morb Mortal Wkly Rep 2002;51:764-6.
3. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med 2002;137:173-9.
4. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001;7:654-8.
5. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile virus fever outbreak, Israel, 2000. Emerg Infect Dis 2001;7:675-8.
6. 2003 West Nile virus activity in the United States (Internet). Atlanta: Centers for Disease Control and Prevention; 2004 [accessed 2004 Jun 2]. Available from: http://www.cdc.gov/ ncidod/dvbid/westnile/ surv&controlCaseCount03_ detailed.htm
7. Harrington T, Kuehnert MJ, Kamel H, et al. West Nile virus infection transmitted by blood transfusion. Transfusion 2003;43:1018-22.
8. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003;349:1236-45.
9. Detection of West Nile virus in blood donation - United States, 2003. MMWR Morb Mortal WkIy Rep 2003;52:769-72.
10. Blood centers begin implementing WNV donor screening tests. ABC Newslett 2003:1-3.
11. Linnen JM, Lewis M, Broulik A, et al. Procleix® WNV assay: a transcription-mediated amplification based assay for screening blood donations for West Nile virus RNA. Transfusion 2003;43S:129A.
12. Gallarda JL, Cheng L, Pai A, et al. Non-clinical performance of the Roche TaqScreen™ West Nile virus system. Transfusion 2003;43S:129A.
13. Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 2000;38: 4066-71.
14. Martin DA, Muth DA, Brown T, et al. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 2000;38:1823-6.
15. Guidance for industry: revised recommendations for the assessment of donor suitability and blood and blood product safety in cases of known or suspected West Nile virus infection (Internet). Rockville (MD): Center for Biologics Evaluation and Research; 2003 [accessed 2003 Nov 1]. Available from: http://www.fda.gov/cber/gdlns/ wnvguid.htm
16. Update: West Nile virus screening of blood donations and transfusion-associated transmission - United States, 2003. MMWR Morb Mortal Wkly Rep 2004;53:281-4.
17. Schreiber GB, Busch MP, Kleiman SH, et al. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
18. Stramer SL. US NAT yield: where are we after 2 years? Transfus Med 2002;12:243-53.
19. Jackson BR, Busch MP, Stramer SL, Aubuchon JP. The cost-effectiveness of NAT for HIV, HCV and HBV in whole-blood donations. Transfusion 2003;43:721-9.
20. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001;358:261-4.
21. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002;42:1019-26.
22. Chamberland ME. Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products? Clin Infect Dis 2002;34:797-805.